# Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity

> **NCT02496611** · PHASE2 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 100 (actual)

## Conditions studied

- Severe Obesity

## Interventions

- **DRUG:** Weight loss with pharmacotherapy
- **DRUG:** Weight loss without pharmacotherapy

## Key facts

- **NCT ID:** NCT02496611
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2020-08-14
- **Final completion:** 2020-08-14
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02496611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02496611, "Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02496611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*